CRISPR Gene Therapy Slashes Hereditary Angioedema Attacks

(MedPage Today) -- Novel in vivo CRISPR-based therapy lonvoguran ziclumeran (lonvo-z) dramatically lowered hereditary angioedema (HAE) attack frequency in the HAELO randomized trial.
HAE attacks dropped by a relative 87% after the single infusion...